Cargando…

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

SIMPLE SUMMARY: Liver functional reserve plays a critical role in the management of hepatocellular carcinoma (HCC) patients. The model for end-stage liver disease (MELD) is used to assess liver functional reserve in HCC patients. Alternatively, the albumin-bilirubin (ALBI) score and easy (EZ)-ALBI s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093004/
https://www.ncbi.nlm.nih.gov/pubmed/37046586
http://dx.doi.org/10.3390/cancers15071925
_version_ 1785023481039028224
author Ho, Shu-Yein
Liu, Po-Hong
Hsu, Chia-Yang
Huang, Yi-Hsiang
Liao, Jia-I
Su, Chien-Wei
Hou, Ming-Chih
Huo, Teh-Ia
author_facet Ho, Shu-Yein
Liu, Po-Hong
Hsu, Chia-Yang
Huang, Yi-Hsiang
Liao, Jia-I
Su, Chien-Wei
Hou, Ming-Chih
Huo, Teh-Ia
author_sort Ho, Shu-Yein
collection PubMed
description SIMPLE SUMMARY: Liver functional reserve plays a critical role in the management of hepatocellular carcinoma (HCC) patients. The model for end-stage liver disease (MELD) is used to assess liver functional reserve in HCC patients. Alternatively, the albumin-bilirubin (ALBI) score and easy (EZ)-ALBI score, platelet-albumin-bilirubin (PALBI) score and platelet-albumin (PAL) score are also proposed to indicate liver reserve in HCC. We aimed to compare these four albumin-based liver reserve models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for HCC patients undergoing transarterial chemoembolization (TACE). Among these models, the PALBI grade had the highest homogeneity and lowest corrected Akaike information criteria value, followed by EZ-ALBI, PAL, ALBI and lastly, MELD. All four albumin-based liver reserve models are better prognostic tools than MELD scores in patients undergoing TACE. Of these, the PALBI score is the best model to evaluate the liver reserve and should be considered a surrogate marker in these patients. ABSTRACT: (1) Background: The severity of liver functional reserve plays an important role in the management of hepatocellular carcinoma (HCC). Noninvasive models such as the model for end-stage liver disease (MELD), albumin-bilirubin (ALBI) grade and easy (EZ)-ALBI grade, platelet-albumin-bilirubin (PALBI) and platelet-albumin (PAL) are used to evaluate liver dysfunction. We aimed to compare the prognostic performance of these four albumin-based models against MELD in HCC patients undergoing transarterial chemoembolization (TACE). (2) Methods: A total of 1038 treatment naïve HCC patients who received TACE as the primary treatment were enrolled. A multivariate Cox model was used to determine independent survival predictors. (3) Results: Multivariate analysis revealed that higher serum creatinine and α-fetoprotein level, vascular invasion, large tumor size, ALBI grades 2–3, EZ-ALBI grades 2–3, PALBI grades 2–3, PAL grades 2–3, but not the MELD score, were independent predictors associated with decreased survival in different Cox models. Among these models, the PALBI grade had the highest homogeneity and lowest corrected Akaike information criteria value, followed by EZ-ALBI, PAL, ALBI and, lastly, MELD. (4) Conclusions: All four albumin-based liver reserve models are better prognostic tools than MELD score in HCC patients undergoing TACE. Of these, the PALBI score is the best model to evaluate the liver reserve and should be considered a surrogate marker in these patients.
format Online
Article
Text
id pubmed-10093004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100930042023-04-13 Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Ho, Shu-Yein Liu, Po-Hong Hsu, Chia-Yang Huang, Yi-Hsiang Liao, Jia-I Su, Chien-Wei Hou, Ming-Chih Huo, Teh-Ia Cancers (Basel) Article SIMPLE SUMMARY: Liver functional reserve plays a critical role in the management of hepatocellular carcinoma (HCC) patients. The model for end-stage liver disease (MELD) is used to assess liver functional reserve in HCC patients. Alternatively, the albumin-bilirubin (ALBI) score and easy (EZ)-ALBI score, platelet-albumin-bilirubin (PALBI) score and platelet-albumin (PAL) score are also proposed to indicate liver reserve in HCC. We aimed to compare these four albumin-based liver reserve models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for HCC patients undergoing transarterial chemoembolization (TACE). Among these models, the PALBI grade had the highest homogeneity and lowest corrected Akaike information criteria value, followed by EZ-ALBI, PAL, ALBI and lastly, MELD. All four albumin-based liver reserve models are better prognostic tools than MELD scores in patients undergoing TACE. Of these, the PALBI score is the best model to evaluate the liver reserve and should be considered a surrogate marker in these patients. ABSTRACT: (1) Background: The severity of liver functional reserve plays an important role in the management of hepatocellular carcinoma (HCC). Noninvasive models such as the model for end-stage liver disease (MELD), albumin-bilirubin (ALBI) grade and easy (EZ)-ALBI grade, platelet-albumin-bilirubin (PALBI) and platelet-albumin (PAL) are used to evaluate liver dysfunction. We aimed to compare the prognostic performance of these four albumin-based models against MELD in HCC patients undergoing transarterial chemoembolization (TACE). (2) Methods: A total of 1038 treatment naïve HCC patients who received TACE as the primary treatment were enrolled. A multivariate Cox model was used to determine independent survival predictors. (3) Results: Multivariate analysis revealed that higher serum creatinine and α-fetoprotein level, vascular invasion, large tumor size, ALBI grades 2–3, EZ-ALBI grades 2–3, PALBI grades 2–3, PAL grades 2–3, but not the MELD score, were independent predictors associated with decreased survival in different Cox models. Among these models, the PALBI grade had the highest homogeneity and lowest corrected Akaike information criteria value, followed by EZ-ALBI, PAL, ALBI and, lastly, MELD. (4) Conclusions: All four albumin-based liver reserve models are better prognostic tools than MELD score in HCC patients undergoing TACE. Of these, the PALBI score is the best model to evaluate the liver reserve and should be considered a surrogate marker in these patients. MDPI 2023-03-23 /pmc/articles/PMC10093004/ /pubmed/37046586 http://dx.doi.org/10.3390/cancers15071925 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ho, Shu-Yein
Liu, Po-Hong
Hsu, Chia-Yang
Huang, Yi-Hsiang
Liao, Jia-I
Su, Chien-Wei
Hou, Ming-Chih
Huo, Teh-Ia
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
title Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
title_full Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
title_fullStr Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
title_full_unstemmed Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
title_short Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
title_sort comparison of four albumin-based liver reserve models (albi/ez-albi/palbi/pal) against meld for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093004/
https://www.ncbi.nlm.nih.gov/pubmed/37046586
http://dx.doi.org/10.3390/cancers15071925
work_keys_str_mv AT hoshuyein comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT liupohong comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT hsuchiayang comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT huangyihsiang comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT liaojiai comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT suchienwei comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT houmingchih comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization
AT huotehia comparisonoffouralbuminbasedliverreservemodelsalbiezalbipalbipalagainstmeldforpatientswithhepatocellularcarcinomaundergoingtransarterialchemoembolization